Safety and Clinical Effectiveness of A3 SVF in Osteoarthritis

Recruiting

A3 SVFSafety and Clinical Effectiveness of A3 SVF in Osteoarthritis

Sponsor:

Institute of Regenerative and Cellular Medicine

Code:

NCT01947348

Conditions

Osteoarthritis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

treatment with A3 SVF

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by Institute of Regenerative and Cellular Medicine on 2014-09-04.